Cagrilintide (2.5 mg) + Semaglutide (2.5 mg) – Lyophilized Powder
Cagrilintide (2.5 mg) + Semaglutide (2.5 mg) is a dual-peptide formulation widely studied for its role in metabolic regulation, appetite modulation, and energy balance pathways. This combination is designed to support advanced research into glucose homeostasis, satiety signaling, and endocrine-related metabolic mechanisms.
Commonly explored in experimental models of metabolic function, this peptide combination is associated with influencing appetite control pathways, supporting glucose-dependent signaling, and modulating energy intake and utilization processes.
Key Research Mechanisms
- GLP-1 Receptor Activation: Investigated for stimulating glucose-dependent insulin signaling and supporting metabolic regulation pathways.
- Amylin Receptor Modulation: Studied for its role in enhancing satiety signaling and influencing gastric motility.
- Appetite & Energy Regulation: Explored for modulating central pathways involved in hunger, caloric intake, and energy balance.
Technical Specifications
| Common Name | Cagrilintide (2.5 mg) + Semaglutide (2.5 mg) |
| Form | Lyophilized Powder (Freeze-Dried) |
| Composition | Cagrilintide (2.5 mg), Semaglutide (2.5 mg) |
| Biological Role | Dual-peptide formulation studied for metabolic regulation, appetite modulation, and glucose homeostasis |
| Purity | ≥ 99% (HPLC) |
| Storage | Store at -20°C for long-term stability. Reconstituted solutions should be stored at 2–8°C and used promptly. Protect from light and moisture. |
⚠️ DISCLAIMER: FOR RESEARCH PURPOSES ONLY
This product is strictly intended for in-vitro laboratory research and development use only. Cagrilintide + Semaglutide is not approved for human or animal consumption, therapeutic applications, or diagnostic use. Must be handled by qualified research professionals.
Reviews
There are no reviews yet.